KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) FCF Margin: 2010-2025

Historic FCF Margin for Pacira BioSciences (PCRX) over the last 15 years, with Sep 2025 value amounting to 31.73%.

  • Pacira BioSciences' FCF Margin rose 217.00% to 31.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.33%, marking a year-over-year decrease of 1052.00%. This contributed to the annual value of 25.50% for FY2024, which is 484.00% up from last year.
  • As of Q3 2025, Pacira BioSciences' FCF Margin stood at 31.73%, which was up 516.92% from 5.14% recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' FCF Margin peaked at 36.96% during Q3 2021, and registered a low of -0.83% during Q1 2021.
  • Its 3-year average for FCF Margin is 21.58%, with a median of 25.04% in 2023.
  • In the last 5 years, Pacira BioSciences' FCF Margin spiked by 4,693bps in 2021 and then plummeted by 2,387bps in 2025.
  • Quarterly analysis of 5 years shows Pacira BioSciences' FCF Margin stood at 8.83% in 2021, then soared by 1,243bps to 21.25% in 2022, then spiked by 401bps to 25.26% in 2023, then tumbled by 870bps to 16.56% in 2024, then surged by 217bps to 31.73% in 2025.
  • Its last three reported values are 31.73% in Q3 2025, 5.14% for Q2 2025, and 15.93% during Q1 2025.